A Polyclonal v Monoclonal Approach to FLC Measurement
Session Overview from the 7th International Symposium: Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis
Session Overview from the 7th International Symposium: Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis
There are several promising areas of research that could enable earlier diagnosis of Alzheimer’s disease
Dr. Andy Golden, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), explores the value of C. elegans as an animal model for research
How Molecular Diagnostics is revolutionizing the way infectious diseases are diagnosed
Guest Editor, Randall Evans, Ph.D of Biodesix, discusses the recent success of a clinical trial of a diagnostic blood test
PCR oligonucleotide primer sets consisting of 16 primers for amplification and 16 primers for cloning of human IgG and IgM heavy and light chain variable domain coding regions for generating universal, patient or antibody-specific scFv phage-display libraries.
Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications.
Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications.
Watch this on-demand webinar to learn how risk-based approaches can be implemented to improve the control of impurities
Join a panel of scientific experts as they reveal groundbreaking COVID-19 and cancer research projects, share insights into cryogenics, and explore why we no longer need to rely on liquid nitrogen based cryogenic freezers for sample storage
Dr. Joseph Hughes describes how WuXi Advanced Therapies scales up viral vectors to help customers expedite entry of gene and cell therapies into clinical trials
Read how Dr Jason Sylvan samples microbes from the depths of the ocean and performs experiments on a ship
Discover how Dr. Nicholas Zachos, Johns Hopkins Medicine, uses patient-derived stem cells to create complex co-cultures with the aim of developing new therapeutics to prevent diarrheal disease
If managed properly, research suggests the land under our feet could offset a significant amount of carbon emissions
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
For such a rapidly growing scientific industry bottlenecked by stigma and prohibition, working together is the only answer, says Dr. John S Abrams, Scientific Director of the Emerald Conference
Meet the couple combining stroke research & Alzheimer’s expertise in the hope of understanding mixed dementia
Researchers at Queen’s University, Canada, explain how their new core facility and its cutting-edge flow cytometry and cell sorting technology are accelerating cardiopulmonary research